Please assess the completion status of the following clinical trial:

Trial Title: Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient has a St Jude Medial device that is compatible with Merlin.net (remote monitoring)~* Patient has history of atrial fibrillation (non-continuous)~* Patient must be taking a a blood thinner medication other than warfarin or aspirin for atrial fibrillation~* Patient is willing to complete a questionnaire~Exclusion Criteria:~* Patient is in atrial fibrillation all of the time~* Patient has a history of stroke or blood clot~* Patient is on warfarin or coumadin~* Patient cannot be taken off of his blood thinner medication due to another medical condition~* Patient is not capable of sending a remote device transmission to doctor once a week

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control (Type: NO_INTERVENTION): Remote transmissions were scheduled per each institution's device monitoring protocol. Anticoagulation was initiated/discontinued based on standard of care/guidelines as prescribed by doctor
- Tailored Anticoagulation (TAC) (Type: EXPERIMENTAL): Anticoagulation was initiated or discontinued based on atrial tachycardia / atrial fibrillation (AT/AF) burden as assessed through frequent remote transmissions via Merlin.net.~Patients sent in biweekly remote transmissions, automatic alert-triggered transmissions for AT/AF burden above a set threshold, and unscheduled patient-activated transmissions as needed

Based on this trial design, predict the completion outcome and termination type (if applicable).